Abstract
Despite high levels of air pollution in the Middle East, there are relatively few studies of its impacts on population health. In this study, associations between short-term exposure to PM2.5 and PM10-2.5 and hospitalization for cardiovascular diseases (CVDs) were evaluated in a study from Isfahan, Iran. In a bidirectional case-crossover design, patients who lived in Isfahan and were admitted with a CVD diagnosis in one of 15 hospitals between March 2010 and to March 2012 were included. Time-stratified conditional logistic regression with covariates of SO2 level, weekend/weekday, temperature, dew point, and wind speed was applied to quantify the odds ratio of CVD admission per interquartile range (IQR) increase in PM. Mean (IQR) concentrations of PM2.5 and PM10-2.5 were 60.1 (39.00–63.00) and 62.4 (37.88–93.00) µg/m3, respectively, with 25,541 CVD admissions. There were indications of small (1–2% per IQR) increases in risk of admissions that were robust to covariate adjustment with no discernable patterns for different lags. For both PM2.5 and PM10-2.5, there were indications of larger associations for female gender and younger ages. For PM2.5, much higher ORs were observed in summer (1.21 (0.95 CI: 1.12, 1.31)) and autumn (1.14 (1.07, 1.21)) for lag period 0–1; while the PM10-2.5 effect was most prominent in autumn (1.28 (1.22, 1.33)). Small increases in risk of CVD admission were associated with exposure to fine and coarse particle levels with high seasonal variability.
Similar content being viewed by others
References
Adar SD, Filigrana PA, Clements N, Peel JL (2014) Ambient coarse particulate matter and human health: a systematic review and meta-analysis. Current Environ Health Reports 1(3):258–274. https://doi.org/10.1007/s40572-014-0022-z
Al Hanai AH, Antkiewicz DS, Hemming JDC, Shafer MM, Lai AM, Arhami M, Schauer JJ (2019) Seasonal variations in the oxidative stress and inflammatory potential of PM2. 5 in Tehran using an alveolar macrophage model; the role of chemical composition and sources. Environ Int 123:417–427
Bell ML, Son J-Y, Peng RD, Wang Y, Dominici F (2015) Ambient PM2. 5 and risk of hospital admissions do risks differ for men and women? Epidemiol (Cambridge Mass) 26(4):575
Bell ML, Zanobetti A, Dominici F (2013) Evidence on vulnerability and susceptibility to health risks associated with short-term exposure to particulate matter: a systematic review and meta-analysis. Am J Epidemiol 178(6):865–876. https://doi.org/10.1093/aje/kwt090
Bowry ADK, Lewey J, Dugani SB, Choudhry NK (2015) The burden of cardiovascular disease in low- and middle-income countries: epidemiology and management. Can J Cardiol 31(9):1151–1159. https://doi.org/10.1016/j.cjca.2015.06.028
Brauer M, Freedman G, Frostad J, van Donkelaar A, Martin RV, Dentener F, Cohen A (2016) Ambient air pollution exposure estimation for the Global Burden of Disease 2013. Environ Sci Technol 50(1):79–88. https://doi.org/10.1021/acs.est.5b03709
Burroughs Peña MS, Rollins A (2017) Environmental exposures and cardiovascular disease: a challenge for health and development in low- and middle-income countries. Cardiol Clin 35(1):71–86. https://doi.org/10.1016/j.ccl.2016.09.001
Carracedo-Martínez E, Taracido M, Tobias A, Saez M, Figueiras A (2010) Case-crossover analysis of air pollution health effects: a systematic review of methodology and application. Environ Health Perspect 118(8):1173–1182. https://doi.org/10.1289/ehp.0901485
Chang C-C, Chen P-S, Yang C-Y (2015) Short-term effects of fine particulate air pollution on hospital admissions for cardiovascular diseases: a case-crossover study in a tropical city. J Toxicol Environ Health A 78(4):267–277. https://doi.org/10.1080/15287394.2014.960044
Chen D, Zhang F, Yu C, Jiao A, Xiang Q, Yu Y, Zhang Y (2019) Hourly associations between exposure to ambient particulate matter and emergency department visits in an urban population of Shenzhen. China. Atmospheric Environ 209((December 2018)):78–85. https://doi.org/10.1016/j.atmosenv.2019.04.021
Chen Y-C, Weng Y-H, Chiu Y-W, Yang C-Y (2015) Short-term effects of coarse particulate matter on hospital admissions for cardiovascular diseases: a case-crossover study in a tropical city. J Toxicol Environ Health A 78(19):1241–1253
Chiu H-F, Tsai S-S, Weng H-H, Yang C-Y (2013) Short-term effects of fine particulate air pollution on emergency room visits for cardiac arrhythmias: a case-crossover study in Taipei. J Toxicol Environ Health A 76(10):614–623. https://doi.org/10.1080/15287394.2013.801763
Cohen AJ, Brauer M, Burnett R, Anderson HR, Frostad J, Estep K, Forouzanfar MH (2017) Estimates and 25-year trends of the global burden of disease attributable to ambient air pollution: an analysis of data from the Global Burden of Diseases Study 2015. The Lancet 389(10082):1907–1918. https://doi.org/10.1016/S0140-6736(17)30505-6
Gaziano TA, Bitton A, Anand S, Abrahams-Gessel S, Murphy A (2010) Growing epidemic of coronary heart disease in low- and middle-income countries. Curr Probl Cardiol 35:72–115. https://doi.org/10.1016/j.cpcardiol.2009.10.002
Hadley MB, Vedanthan R, Fuster V (2018) Air pollution and cardiovascular disease: a window of opportunity. Nat Rev Cardiol 15(4):193–194. https://doi.org/10.1038/nrcardio.2017.207
He F, Shaffer ML, Rodriguez-colon S, Yanosky JD, Bixler E, Cascio WE (2011) Acute effects of fine particulate air pollution on cardiac arrhythmia: the APACR study. Environ Health Perspect 119(7):927–932. https://doi.org/10.1289/ehp.1002640
Hwang, S., Chi, M., Guo, S., Lin, Y., Chou, C., Lin, C. (2018). Seasonal variation and source apportionment of PM 2 . 5 -bound trace elements at a coastal area in southwestern Taiwan, 9101–9113.
Ito K, Mathes R, Ross Z, Nádas A, Thurston G, Matte T (2010) Fine particulate matter constituents associated with cardiovascular hospitalizations and mortality in New York City. Environ Health Perspect 119(4):467–473
Janes H, Sheppard L, Lumley T (2005) Case-crossover analyses of air pollution exposure data. Epidemiology 16(6):717–726. https://doi.org/10.1097/01.ede.0000181315.18836.9d
Kermani M, Goudarzi G, Shahsavani A, Dowlati M, Asl FB, Karimzadeh S, Tabibi R (2018) Estimation of short-term mortality and morbidity attributed to fine particulate matter in the ambient air of eight Iranian cities. Annals of Global Health 84(3):408–418. https://doi.org/10.29024/aogh.2308
Khazaei M, Darejeh M, Beigi AM, Fahiminia M (2016) Patterns of annual fluctuation of dust concentrations along with meteorological parameters : a case study in Qom province, central Iran. JAir Pollut Health 1(Spring):99–110
Landrigan PJ, Fuller R, Acosta NJR, Adeyi O, Arnold R, Basu N(Nil), Zhong M (2018) The Lancet Commission on pollution and health. The Lancet 391(10119):462–512. https://doi.org/10.1016/S0140-6736(17)32345-0
Liang R, Zhang B, Zhao X, Ruan Y, Lian H, Fan Z (2014) Effect of exposure to PM2. 5 on blood pressure a systematic review and meta-analysis. J Hypertension 32(11):2130–2141
Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, George S (2012) A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet 380:2224–2260. https://doi.org/10.1016/S0140-6736(12)61766-8
Luo C, Zhu X, Yao C, Hou L, Zhang J, Cao J, Wang A (2015) Short-term exposure to particulate air pollution and risk of myocardial infarction: a systematic review and meta-analysis. Environ Sci Pollut Res 22(19):14651–14662
Ma Y, Zhang H, Zhao Y, Zhou J, Yang S (2017) Short-term effects of air pollution on daily hospital admissions for cardiovascular diseases in western China. Environ Sci Pollut Res 24:14071–14079. https://doi.org/10.1007/s11356-017-8971-z
Marzouni MB, Moradi M, Zarasvandi A, Akbaripoor S, Hassanvand MS, Neisi A, Barari K (2017) Health benefits of PM10 reduction in Iran. Int J Biometeorol. https://doi.org/10.1007/s00484-017-1316-2
Newell K, Kartsonaki C, Bong K, Lam H, Kurmi OP (2017) Cardiorespiratory health effects of particulate ambient air pollution exposure in low-income and middle-income countries : a systematic review and meta-analysis. The Lancet Planetary Health 1(9):e368–e380. https://doi.org/10.1016/S2542-5196(17)30166-3
Nuvolone D, Balzi D, Chini M, Scala D, Giovannini F, Barchielli A (2011) Short-term association between ambient air pollution and risk of hospitalization for acute myocardial infarction: results of the cardiovascular risk and air pollution in Tuscany (RISCAT) study. Am J Epidemiol 174(1):63–71
Rabiei K, Hosseini SM, Sadeghi E, Jafari-Koshki T, Rahimi M, Shishehforoush M, Mohebi MB (2017) Air pollution and cardiovascular and respiratory disease: rationale and methodology of CAPACITY study. ARYA Atherosclerosis 13(6):264
Rubin, DB. (2004). Multiple imputation for nonresponse in surveys (Vol. 81). John Wiley & Sons.
Shah ASV, Langrish JP, Nair H, Mcallister DA, Hunter AL, Donaldson K, Mills NL (2013) Global association of air pollution and heart failure a systematic review and meta analysis. The Lancet 382:21. https://doi.org/10.1016/S0140-6736(13)60898-3
Shah ASV, Lee KK, McAllister DA, Hunter A, Nair H, Whiteley W, Mills NL (2015) Short term exposure to air pollution and stroke: systematic review and meta-analysis. The BMJ 350:h1295. https://doi.org/10.1136/BMJ.H1295
Shin HH, Fann N, Burnett RT, Cohen A, Hubbell BJ (2014) Outdoor fine particles and nonfatal strokes: systematic review and meta-analysis. Epidemiology Cambridge, Mass 25(6):835
Sicard, P., Khaniabadi, YO., Perez, S., Gualtieri, M., Marco, A. De. (2019). Effect of O3 , PM10 and PM2.5 on cardiovascular and respiratory diseases in cities of France , Iran and Italy, 32645–32665.
Soleimani Z, Teymouri P, Darvishi A, Mesdaghinia A, Middleton N, Griffin DW (2020) An overview of bioaerosol load and health impacts associated with dust storms : a focus on the Middle East. Atmospheric Environ 223((July2019)):117187. https://doi.org/10.1016/j.atmosenv.2019.117187
Song X, Liu Y, Hu Y, Zhao X, Tian J, Ding G, Wang S (2016) Short-term exposure to air pollution and cardiac arrhythmia: a meta-analysis and systematic review. Int J Environ Res Public Health 13(7):642. https://doi.org/10.3390/ijerph13070642
Su C, Breitner S, Schneider A, Liu L, Franck U, Peters A, Pan X (2016) Short-term effects of fine particulate air pollution on cardiovascular hospital emergency room visits: a time-series study in Beijing, China. Int Arch Occup Environ Health 89(4):641–657. https://doi.org/10.1007/s00420-015-1102-6
Talebi, SM., Tavakoli-Ghinani, T. (2008). Levels of PM10 and its chemical composition in the atmosphere of the city of Isfahan. Iranian Journal of Chemical Engineering(IJChE), 5(3), 62–67. Retrieved from http://www.ijche.com/article_15184.html
Tsiouri V, Kakosimos KE, Kumar P (2015) Concentrations, sources and exposure risks associated with particulate matter in the Middle East Area—a review. Air Qual Atmos Health 8:67–80. https://doi.org/10.1007/s11869-014-0277-4
Wang Y, Eliot MN, Wellenius GA (2014) Short-term changes in ambient particulate matter and risk of stroke: a systematic review and meta-analysis. J Am Heart Assoc 3(4):1–22. https://doi.org/10.1161/JAHA.114.000983
Zanobetti A, Schwartz J (2005) The effect of particulate air pollution on emergency admissions for myocardial infarction: a multicity case-crossover analysis. Environ Health Perspect 113(8):978–982. https://doi.org/10.1289/EHP.7550
Funding
This study was financially supported by the Crisis Management Office of Isfahan Provincial Governor, and Isfahan’s Department of Environment (grant number 90/7588).
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Appendices
Appendix 1 Time series plot of PM2.5 and PM10-2.5
Appendix 2 Correlation matrix of PM and SO2 levels and meteorological variables
Season | PM10 | PM2.5 | PM10-2.5 | SO2 | Temperature | Dew point | Wind Speed | ||
---|---|---|---|---|---|---|---|---|---|
Spring | PM10 | r * | .692 | .936 | − .086 | .305 | .153 | .182 | |
p value | < 0.001 | < 0.001 | .241 | < 0.001 | .037 | .013 | |||
PM2.5 | r * | .692 | .393 | .075 | .170 | − .199 | .211 | ||
p value | < 0.001 | < 0.001 | .475 | .104 | .056 | .042 | |||
PM10-2.5 | r * | .936 | .393 | .234 | .297 | .245 | .307 | ||
p value | .000 | .000 | .024 | .004 | .018 | .003 | |||
SO2 | r * | − .086 | .075 | .234 | .318 | − .148 | − .008 | ||
p value | .241 | .475 | .024 | < 0.001 | .043 | .918 | |||
Summer | PM10 | r * | .652 | .962 | .256 | .084 | − .011 | .154 | |
p value | < 0.001 | < 0.001 | < 0.001 | .257 | .882 | .035 | |||
PM2.5 | r * | .652 | .420 | .520 | .375 | .174 | .299 | ||
p value | < 0.001 | < 0.001 | < 0.001 | < 0.001 | .096 | .004 | |||
PM10-2.5 | r * | .962 | .420 | .401 | .210 | .214 | .242 | ||
p value | < 0.001 | < 0.001 | < 0.001 | .044 | .039 | .020 | |||
SO2 | r * | .256 | .520 | .401 | .436 | − .065 | .158 | ||
p value | < 0.001 | < 0.001 | < 0.001 | < 0.001 | .379 | .031 | |||
Autumn | PM10 | r * | .703 | .915 | − .106 | − .182 | − .492 | − .240 | |
p value | < 0.001 | < 0.001 | .155 | .014 | < 0.001 | .001 | |||
PM2.5 | r * | .703 | .355 | .294 | − .292 | − .329 | − .297 | ||
p value | < 0.001 | .001 | .005 | .005 | .002 | .004 | |||
PM10-2.5 | r * | .915 | .355 | .052 | − .014 | − .313 | .022 | ||
p value | < 0.001 | .001 | .625 | .899 | .003 | .838 | |||
SO2 | r * | − .106 | .294 | .052 | − .432 | − .077 | − .125 | ||
p value | .155 | .005 | .625 | < 0.001 | .307 | .096 | |||
Winter | PM10 | r * | .485 | .901 | − .201 | .057 | − .098 | − .095 | |
p value | < 0.001 | < 0.001 | .007 | .450 | .193 | .209 | |||
PM2.5 | r * | .485 | .058 | − .266 | .132 | .320 | .027 | ||
p value | < 0.001 | .592 | .012 | .217 | .002 | .804 | |||
PM10-2.5 | r * | .901 | .058 | − .071 | .396 | .116 | .325 | ||
p value | < 0.001 | .592 | .507 | < 0.001 | .277 | .002 | |||
SO2 | r * | − .201 | − .266 | − .071 | .152 | − .089 | .299 | ||
p value | .007 | .012 | .507 | .043 | .240 | < 0.001 | |||
Total | PM10 | r * | .629 | .914 | − .029 | .067 | − .028 | − .098 | |
p value | < 0.001 | < 0.001 | .437 | .069 | .442 | .008 | |||
PM2.5 | r * | .629 | .260 | .123 | .158 | .210 | − .124 | ||
p value | < 0.001 | < 0.001 | .018 | .002 | < 0.001 | .018 | |||
PM10-2.5 | r * | .914 | .260 | .137 | .044 | .041 | .204 | ||
p value | < 0.001 | < 0.001 | .009 | .399 | .433 | < 0.001 | |||
SO2 | r * | − .029 | .123 | .137 | − .318 | − .191 | − .043 | ||
p value | .437 | .018 | .009 | < 0.001 | < 0.001 | .241 |
Appendix 3 Quartiles of PM2.5, PM10-2.5, and PM10 during the study period (µg/m.3)
Quartiles | PM2.5 | PM10 | PM10-2.5 | |
---|---|---|---|---|
Overall | Q1 | 8.00–39.00 | 38.46–99.47 | 0.12–37.88 |
Q2 | 39.00–51.00 | 99.47–150.16 | 37.88–62.00 | |
Q3 | 51.00–62.00 | 150.16–170.43 | 62.00–93.00 | |
Q4 | 62.00–130.00 | 170.43–349.06 | 93.00–227 | |
Spring | Q1 | 23.06–32.00 | 44.67–106.59 | 10.86–57.41 |
Q2 | 32.00–43.00 | 106.59–143.48 | 57.41–72.67 | |
Q3 | 43.00–54.00 | 143.48–166.22 | 72.67–100.5 | |
Q4 | 54.00–100.07 | 166.22–263.03 | 100.5–177.00 | |
Summer | Q1 | 32.14–49.00 | 57.33–69.62 | 0.12–30.17 |
Q2 | 49.00–57.00 | 96.62–157.65 | 30.17–43.33 | |
Q3 | 57.00–66.04 | 157.65–170.37 | 43.33–79.79 | |
Q4 | 66.04–111.00 | 170.37–324.00 | 79.79–227.00 | |
Autumn | Q1 | 13.09–50.00 | 57.50–126.83 | 3.33–45.93 |
Q2 | 50.00–55.50 | 126.83–166.92 | 45.93–74.5 | |
Q3 | 55.50–68.25 | 166.92–182.17 | 74.5–104.17 | |
Q4 | 69.25–130.00 | 182.17–349.06 | 10.17–178.33 | |
Winter | Q1 | 8.00–26.00 | 38.46–75.27 | 2.05–33.62 |
Q2 | 26.00–40.33 | 75.27–123.59 | 33.62–50.00 | |
Q3 | 40.33–52.99 | 123.59–155.60 | 50.00–82.11 | |
Q4 | 52.99–96.05 | 155.60–267.39 | 82.11–161.02 |
Appendix 4 Crude and adjusted odds ratios for an IQR increase in PM2.5 and PM10-2.5 for lag period 0-1 stratified by diagnostic categories
Diagnosis category | PM2.5 | PM10-2.5 | ||||
---|---|---|---|---|---|---|
Crude OR (95%CI) | Adjusted OR* (95%CI) | Adjusted OR¶ (0.95 CI) | Crude OR (95%CI) | Adjusted OR* (95%CI) | Adjusted OR¶ (0.95 CI) | |
Hypertensive heart disease (I10–I15) | 1.01 (0.94–1.08) | 1.00 (0.93–1.08) | 0.99 (0.93, 1.08) | 1.03 (0.98–1.09) | 1.03 (0.97–1.09) | 1.02 (0.96, 1.08) |
Ischemic heart diseases (I20–I25) | 1.00 (0.97–1.04) | 1.00 (0.96–1.04) | 1.01 (0.98, 1.05) | 1.02 (0.99–1.05) | 1.01 (0.98–1.04) | 1.02 (0.99, 1.05) |
Conduction disorders and blocks (I44–I45) | 0.99 (0.79–1.27) | 0.98 (0.77–1.26) | 0.99 (0.77, 1.29) | 1.05 (0.85–1.29) | 1.04 (0.84–1.29) | 1.01 (0.82, 1.26) |
Cardiac arrest (I46) | 1.12 (0.93–1.34) | 1.12 (0.93–1.35) | 1.09 (0.90, 1.32) | 1.03 (0.89–1.19) | 1.01 (0.87–1.17) | 1.04 (0.89, 1.22) |
Arrhythmias (I47–I49) | 1.01 (0.89–1.13) | 0.98 (0.87–1.11) | 1.02 (0.89, 1.16) | 1.06 (0.97–1.16) | 1.03 (0.94–1.13) | 1.07 (0.96, 1.17) |
Heart failure (I50) | 1.08 (0.97–1.20) | 1.08 (0.97–1.21) | 1.06 (0.94, 1.18) | 0.98 (0.89–1.07) | 0.97 (0.89–1.07) | 1.02 (0.93, 1.12) |
Cerebrovascular diseases (I60–I69) | 0.97 (0.89–1.05) | 0.97 (0.89–1.06) | 1.02 (0.94, 1.11) | 1.03 (0.96–1.10) | 1.03 (0.96–1.10) | 1.04 (0.97, 1.11) |
Other and unspecified disorders of circulatory system (I99) | 1.03 (0.95–1.12) | 1.03 (0.95–1.12) | 1.05 (0.97, 1.15) | 1.08 (1.01–1.16) | 1.07 (0.99–1.14) | 1.07 (1.00, 1.15) |
Appendix 5 Crude and adjusted odds ratios for an IQR increase in PM10 in relation to all cardiovascular diseases for lag period 0-1, stratified by gender, age groups, and season
Overall disease | PM10 | |||
---|---|---|---|---|
Crude OR (0.95 CI) | Adjusted OR* (0.95 CI) | Adjusted OR¶ (0.95 CI) | ||
Gender | Female | 1.08 (1.05–1.11) | 1.08 (1.05–1.11) | 1.04 (1.01, 1.07) |
Male | 1.04 (1.01–1.07) | 1.03 (1.01–1.06) | 1.02 (0.99, 1.04) | |
Age group | < 35 | 1.08 (1.02–1.14) | 1.07 (1.01–1.13) | 1.02 (0.97, 1.07) |
35–64 | 1.06 (1.03–1.10) | 1.06 (1.03–1.10) | 1.03 (1.00, 1.06) | |
≥ 65 | 1.06 (1.03–1.10) | 1.06 (1.03–1.10) | 1.03 (1.00, 1.06) | |
Season | Spring | 0.93 (0.90, 0.96) | 0.91 (0.88, 0.94) | 0.89 (0.86, 0.93) |
Summer | 1.03 (0.99, 1.08) | 1.04 (1.00, 1.09) | 1.16 (1.11, 1.21) | |
Autumn | 1.23 (1.19, 1.27) | 1.25 (1.21, 1.29) | 1.19 (1.14, 1.23) | |
Winter | 1.03 (0.99, 1.07) | 1.06 (1.02, 1.10) | 1.08 (1.04, 1.13) |
Appendix 6 Crude and adjusted odds ratios for an IQR increase in PM10 for lag period 0-1 stratified by diagnostic categories
Diagnosis category | PM10 | ||
---|---|---|---|
Crude OR (95%CI) | Adjusted OR* (95%CI) | Adjusted OR¶ (0.95 CI) | |
Hypertensive heart disease (I10–I15) | 1.04 (0.99, 1.10) | 1.04 (0.98, 1.10) | 1.01 (0.96, 1.06) |
Ischemic heart diseases (I20–I25) | 1.07 (1.03, 1.09) | 1.05 (1.02, 1.08) | 1.02 (0.99, 1.05) |
Conduction disorders and blocks(I44-I45) | 1.11 (0.94, 1.33) | 1.12 (0.94, 1.34) | 1.11 (0.94, 1.32) |
Cardiac arrest (I46) | 1.01 (0.90, 1.16) | 1.02 (0.90, 1.16) | 1.01 (0.89, 1.15) |
Arrhythmias (I47–I49) | 1.08 (0.98, 1.16) | 1.07 (0.98, 1.17) | 1.09 (1.00, 1.18) |
Heart failure (I50) | 1.06 (0.98, 1.14) | 1.06 (0.98, 1.15) | 1.04 (0.96, 1.12) |
Cerebrovascular diseases (I60–I69) | 1.05 (0.99, 1.12) | 1.05 (0.99, 1.12) | 1.03 (0.98, 1.09) |
Other and unspecified disorders of circulatory system (I99) | 1.05 (0.99, 1.12) | 1.06 (0.99, 1.12) | 1.03 (0.98, 1.09) |
Appendix 7 Crude and adjusted odds ratios for an IQR increase in PM2.5 and PM10-2.5 for lag period 0-1 based on gender and age groups in autumn
Overall disease | PM10 | |||
---|---|---|---|---|
Crude OR (95%CI) | Adjusted OR* (95%CI) | Adjusted OR¶ (0.95 CI) | ||
Gender | Female | 1.22 (1.16, 1.28) | 1.25 (1.19, 1.31) | 1.23 (1.16, 1.29) |
Male | 1.17 (1.11, 1.23) | 1.19 (1.13, 1.25) | 1.15 (1.09, 1.21) | |
Age group | < 35 | 1.16 (1.04, 1.29) | 1.18 (1.05, 1.33) | 1.15 (1.02, 1.29) |
35–64 | 1.18 (1.12, 1.24) | 1.21 (1.15, 1.27) | 1.18 (1.12, 1.25) | |
≥ 65 | 1.21 (1.15, 1.28) | 1.24 (1.17, 1.31) | 1.21 (1.14, 1.28) |
Appendix 8 Crude and adjusted odds rations for an IQR increase in PM2.5 and PM10-2.5 stratified by diagnostic categories for lag period 0-1 in autumn
Diagnosis category | PM2.5 | PM10-2.5 | ||||
---|---|---|---|---|---|---|
Crude OR (95%CI) | Adjusted OR* (95%CI) | Adjusted OR¶ (0.95 CI) | Crude OR (95%CI) | Adjusted OR* (95%CI) | Adjusted OR¶ (0.95 CI) | |
Hypertensive heart disease (I10–I15) | 1.07 (0.92, 1.23) | 1.24 (1.13, 1.37) | 1.11 (0.96, 1.29) | 1.12 (0.97, 1.29) | 1.29 (1.16, 1.42) | 1.25 (1.13, 1.39) |
Ischemic heart diseases (I20–I25) | 1.17 (1.08, 1.26) | 1.29 (1.22, 1.36) | 1.17 (1.07, 1.27) | 1.21 (1.12, 1.31) | 1.31 (1.23, 1.38) | 1.27 (1.20, 1.35) |
Conduction disorders and blocks (I44–I45) | 1.19 (0.71, 1.99) | 1.45 (0.99, 2.12) | 1.06 (0.61, 1.87) | 1.16 (0.66, 2.01) | 1.64 (1.09, 2.47) | 1.58 (1.08, 2.30) |
Cardiac arrest (I46) | 1.85 (1.15, 2.99) | 1.37 (1.02, 1.84) | 1.71 (1.05, 2.79) | 1.69 (1.05, 2.73) | 1.30 (0.94, 1.79) | 1.39 (0.97, 1.98) |
Arrhythmias (I47–I49) | 1.03 (0.79, 1.34) | 1.19 (0.99, 1.43) | 1.09 (0.83, 1.44) | 1.14 (0.88, 1.49) | 1.21 (1.00, 1.45) | 1.24 (1.03, 1.51) |
Heart failure (I50) | 1.36 (1.03, 1.79) | 1.15 (0.95, 1.38) | 1.12 (0.84, 1.49) | 1.47 (1.11, 1.94) | 1.19 (0.99, 1.45) | 1.22 (0.99, 1.49) |
Cerebrovascular diseases (I60–I69) | 1.01 (0.85, 1.21) | 1.19 (1.06, 1.35) | 1.07 (0.89, 1.28) | 1.05 (0.87, 1.25) | 1.23 (1.09, 1.40) | 1.26 (1.11, 1.44) |
Other and unspecified disorders of circulatory system (I99) | 0.98 (0.83, 1.16) | 1.37 (1.21, 1.55) | 1.01 (0.85, 1.21) | 1.01 (0.85, 1.19) | 1.39 (1.23, 1.59) | 1.34 (1.18, 1.53) |
Appendix 9 Crude and adjusted odds ratios for an IQR increase in PM10 for lag period 0-1 based on gender and age groups in autumn
Overall disease | PM2.5 | PM10-2.5 | |||||
---|---|---|---|---|---|---|---|
Crude OR (95%CI) | Adjusted OR* (95%CI) | Adjusted OR¶ (0.95 CI) | Crude OR (95%CI) | Adjusted OR* (95%CI) | Adjusted OR¶ (0.95 CI) | ||
Gender | Female | 1.13 (1.05, 1.23) | 1.19 (1.09, 1.29) | 1.13 (1.03, 1.23) | 1.33 (1.26, 1.41) | 1.37 (1.29, 1.45) | 1.34 (1.27, 1.42) |
Male | 1.11 (1.03, 1.20) | 1.16 (1.08, 1.26) | 1.15 (1.05, 1.25) | 1.21 (1.15, 1.28) | 1.25 (1.18, 1.32) | 1.21 (1.14, 1.29) | |
Age group | < 35 | 1.32 (1.10, 1.58) | 1.33 (1.10, 1.59) | 1.20 (0.99, 1.45) | 1.23 (1.09, 1.39) | 1.23 (1.08, 1.39) | 1.24 (1.09, 1.41) |
35–64 | 1.11 (1.03, 1.21) | 1.18 (1.09, 1.29) | 1.14 (1.05, 1.25) | 1.26 (1.19, 1.33) | 1.30 (1.23, 1.38) | 1.26 (1.19, 1.34) | |
≥ 65 | 1.09 (1.00, 1.19) | 1.14 (1.05, 1.24) | 1.11 (1.02, 1.22) | 1.30 (1.22, 1.38) | 1.33 (1.25, 1.41) | 1.30 (1.22, 1.39) |
Appendix 10 Crude and adjusted odds rations for an IQR increase in PM10 stratified by diagnostic categories for lag period 0-1 in autumn
Diagnosis category | PM10 | ||
---|---|---|---|
Crude OR (95%CI) | Adjusted OR* (95%CI) | Adjusted OR¶ (95%CI) | |
Hypertensive heart disease (I10–I15) | 1.17 (1.08, 1.28) | 1.18 (1.08, 1.29) | 1.09 (0.98, 1.19) |
Ischemic heart diseases (I20–I25) | 1.24 (1.18, 1.30) | 1.25 (1.19, 1.31) | 1.20 (1.14, 1.26) |
Conduction disorders and blocks (I44–I45) | 1.45 (1.03, 2.03) | 1.46 (1.03, 2.07) | 1.51 (1.08, 2.09) |
Cardiac arrest (I46) | 1.57 (1.22, 2.02) | 1.51 (1.15, 1.99) | 1.45 (1.09, 1.94) |
Arrhythmias (I47–I49) | 1.17 (0.99, 1.36) | 1.17 (0.99, 1.38) | 1.11 (0.93, 1.31) |
Heart failure (I50) | 1.21 (1.04, 1.43) | 1.22 (1.04, 1.43) | 1.12 (0.93, 1.34) |
Cerebrovascular diseases (I60–I69) | 1.21 (1.09, 1.35) | 1.22(1.09,1.36) | 1.23(1.09,1.38) |
Other and unspecified disorders of circulatory system (I99) | 1.23 (1.10, 1.38) | 1.25 (1.11, 1.39) | 1.23 (1.09, 1.38) |
Rights and permissions
About this article
Cite this article
Karbakhsh, M., Mansourian, M., Taheri, M. et al. Outdoor fine and coarse particles and hospital admissions for cardiovascular diseases: a large-scale case-crossover study. Air Qual Atmos Health 15, 1679–1693 (2022). https://doi.org/10.1007/s11869-022-01212-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11869-022-01212-0